Zuellig Pharma Acquires Cialis® (Tadalafil) From Lilly in Singapore

Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsAbbott Laboratories maintains a diversified business model spanning diagnostics, medical devices, and nutrition products.Eli Lilly is experiencing rapid growth driven by its dominant presence in the cardiometabolic treatment market.Which healthcare stock offers the right balance of stability and growth for your 2026 portfolio?10 stocks we like better than Abbott Laboratories › Choosing between Abbott Laboratories (NYSE:ABT) and Eli Lil…

Zuellig Pharma Acquires Cialis® (Tadalafil) from Lilly in Singapore

SINGAPORE – Media OutReach Newswire – 3 August 2026 – Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to Cialis® (Tadalafil), a leading men’s health product from Eli Lilly and Company (“Lilly”) in Singapore. Following the acquisition, Zuellig Pharma will now […]

Zuellig Pharma acquires Cialis rights from Lilly

SINGAPORE - Media OutReach Newswire - 3 August 2026 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to Cialis®(Tadalafil), a leading men's health product from Eli Lilly and Company ("Lilly") in Singapore. Following the acquisition, Zuellig Pharma will now own the trademarks and marketing authorizations and licenses manufacturing know-how for Cialis®, a …